Literature DB >> 30737808

Brain imaging in classic nonketotic hyperglycinemia: Quantitative analysis and relation to phenotype.

Nicholas V Stence1, Laura Z Fenton1, Claire Levek2, Suhong Tong2, Curtis R Coughlin3, Julia B Hennermann4, Saskia B Wortmann5, Johan L K Van Hove3.   

Abstract

Patients with severe nonketotic hyperglycinemia (NKH) have absent psychomotor development and intractable epilepsy, whereas attenuated patients have variable psychomotor development and absent or treatable epilepsy; differences in brain magnetic resonance imaging (MRI) between phenotypes have not been reported. In a retrospective cross-sectional study, we reviewed 38 MRI studies from 24 molecularly proven NKH patients, and 2 transient NKH patients. Quantitative analyses included corpus callosum size, apparent diffusion coefficient, automated brain volumetric analysis, and glycine/creatine ratio by spectroscopy. All patients age <3 months had restricted diffusion in the posterior limb of the internal capsule, anterior brainstem, posterior tegmental tracts, and cerebellum, not present in transient NKH. In older infants, the pattern evolved and included generalized diffusion restriction in the supratentorial white matter, which quantitatively peaked between 3 and 12 months. No patient had absent corpus callosum or gyral malformation. The corpus callosum was relatively short in severe compared to attenuated phenotypes, and thin in severe cases only. The corpus callosum growth rate differed by severity; age-matched Z-scores of thickness worsened in severe cases only. Cerebral volume was decreased in the hippocampus, globus pallidus, cerebral cortex, thalamus, and cerebellum. Severe patients had greatest glycine/creatine ratios. In this study, no brain malformations were identified. The growth failure of the corpus callosum is worse in severe NKH, whereas the diffusion restriction pattern, reflecting microspongiosis, does not discriminate by phenotypic severity. NKH is therefore a disorder of brain growth best recognized in the corpus callosum, whereas spongiosis is not prognostic.
© 2019 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.

Entities:  

Keywords:  brain magnetic resonance imaging; corpus callosum; diffusion restriction; magnetic resonance spectroscopy; nonketotic hyperglycinemia; phenotypic outcome

Mesh:

Year:  2019        PMID: 30737808     DOI: 10.1002/jimd.12072

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  7 in total

Review 1.  Clinical 1H MRS in childhood neurometabolic diseases - part 2: MRS signatures.

Authors:  Matthew T Whitehead; Lillian M Lai; Stefan Blüml
Journal:  Neuroradiology       Date:  2022-02-28       Impact factor: 2.804

Review 2.  Application of 7T MRS to High-Grade Gliomas.

Authors:  L McCarthy; G Verma; G Hangel; A Neal; B A Moffat; J P Stockmann; O C Andronesi; P Balchandani; C G Hadjipanayis
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

Review 3.  Nonketotic Hyperglycinemia: Insight into Current Therapies.

Authors:  Magdalena Nowak; Piotr Chuchra; Justyna Paprocka
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

4.  Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism.

Authors:  Andrea L Gropman; Afrouz Anderson
Journal:  J Transl Genet Genom       Date:  2020-11-13

5.  Clinical and genetic analysis of nonketotic hyperglycinemia: A case report.

Authors:  Jun-Jie Ning; Feng Li; Sheng-Qiu Li
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

6.  Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia.

Authors:  Michael A Swanson; Kristen Miller; Sarah P Young; Suhong Tong; Lina Ghaloul-Gonzalez; Juanita Neira-Fresneda; Lisa Schlichting; Cheryl Peck; Linda Gabel; Marisa W Friederich; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2022-04-06       Impact factor: 4.750

7.  Genotypic and phenotypic features in Turkish patients with classic nonketotic hyperglycinemia.

Authors:  Harun Bayrak; Yılmaz Yıldız; Asburçe Olgaç; Çiğdem Seher Kasapkara; Aynur Küçükcongar; Ayşegül Zenciroğlu; Deniz Yüksel; Serdar Ceylaner; Mustafa Kılıç
Journal:  Metab Brain Dis       Date:  2021-04-01       Impact factor: 3.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.